However, further experiments are warranted to understand the mechanisms underlying Fn1 inhibition of LKB1-AMPK signaling and test whether Fn1 targeting represents a novel target for intervention of ischemic heart diseases in other animals. This evidence concerns the gene PRKAA2 and coronary artery disorder.